Related Experiment Videos
Homocysteine: predictor of thrombotic disease
1Esoterix Coagulation, Aurora CO 80014, USA. paige.macy@esoterix.com
Insights
Elevated homocysteine levels are linked to cardiovascular and cerebrovascular events, even in individuals without traditional risk factors. Accurate laboratory testing for hyperhomocysteinemia is crucial for identifying this risk.
Area of Science:
- Biochemistry
- Vascular Biology
- Clinical Medicine
Background:
- A significant portion of thrombotic events occur without traditional risk factors.
- Research is exploring alternative predictors for cardiovascular and cerebrovascular diseases.
- Numerous studies confirm a strong association between elevated homocysteine and vascular disease development.
Purpose of the Study:
- To investigate the role of homocysteine as a predictor of thrombotic events.
- To understand the mechanisms by which hyperhomocysteinemia contributes to vascular disease.
- To highlight the importance of accurate homocysteine laboratory assessment.
Main Methods:
- Review of clinical trials linking homocysteine levels to vascular disease.
- Examination of the metabolic pathways and causes of hyperhomocysteinemia.
- Discussion of the pathophysiological effects of elevated homocysteine on the vascular system.
- Evaluation of advancements in homocysteine laboratory testing, including enzyme immunoassay technology.
Main Results:
- Increased homocysteine levels are a definite risk factor for cardiovascular, cerebrovascular, and peripheral vascular diseases.
- Hyperhomocysteinemia results from nutritional deficiencies, pharmaceuticals, or metabolic disorders.
- Elevated homocysteine promotes endothelial damage, platelet hyperactivity, and abnormal clotting, leading to thromboembolic plaques.
- New enzyme immunoassay technologies have improved the availability and ease of homocysteine assessment.
Conclusions:
- Hyperhomocysteinemia is a significant, independent risk factor for thrombotic vascular events.
- Understanding homocysteine metabolism and its impact is vital for preventing vascular disease.
- Accurate laboratory detection of homocysteine requires careful attention to preanalytical variables like sample collection, processing, and storage.
Abstract:
Up to one third of primary cardiovascular and cerebrovascular thrombotic events occur in people who do not have traditional risk factors. This has led the scientific community to look for other potential reasons, i.e., predictors of these events. Numerous clinical trials have demonstrated a definite link between increased levels of homocysteine and the development of cardiovascular, cerebrovascular, and peripheral vascular disease. Hyperhomocysteinemia is caused by a disruption in normal metabolism of homocysteine by lack of nutrition, pharmaceutical agents, and by inherited or acquired disorders associated with this metabolism. Elevated levels of homocysteine promote endothelial cell damage, platelet hyperactivity, and the production of abnormal clotting factors leading to the development of thromboembolic plaques in the coronary, carotid, and peripheral vascular systems. The laboratory assessment of homocysteine has been made easier and more readily available to the clinician by the development of new enzyme immunoassay technology. Preanalytical variables, however, such as collection, processing, and storage are very important considerations for the accurate detection of elevated levels of homocysteine.